Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Dr. Lothar Seefried
With
Alexion Pharmaceuticals, Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age ≥ 18 years at the time of enrollment
Clinical diagnosis of pediatric-onset HPP based on low ALP (age- and sex-adjusted) and/or genetic confirmation of ALPL mutation(s), and clinical symptoms consistent with HPP
Participant currently receiving commercial asfotase alfa treatment for HPP at the Orthopedic Institute of the Julius-Maximilians-University Würzburg, as per standard of care
Willingness to participate in the study
Signed informed consent
You may not be if
Unwillingness / anticipated inability to attend further visits
Off-label treatment with asfotase alfa
Current participation in an Alexion Sponsored Trial